Jenny Andrus, MD
Interventional Pain Medicine · Newport News, VANPI 1851461909
Payments from drug & device makers
What this record shows
6 manufacturers reported payments, led by Boston Scientific at 56.7% of the total. That places this record below the midpoint for interventional pain medicine clinicians in VA, where the typical reported total is $4,360.
Across 38 payments — averaging $112.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$1K
- SPR Therapeutics, Inc$492
- Electronic Waveform Lab, Inc.$18
- Kaleo, Inc.$16
- Johnson & Johnson$12
What the payments were for
- Travel & lodging$2,52659%
- Food & beverage$1,75941%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $2,430 |
| Abbott | 8 | $1,316 |
| SPR Therapeutics, Inc | 4 | $492 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPECTRA WAVEWRITER$1,738
- PROCLAIM$1,022
- SPRINT PNS System$319
- GENERAL PAIN MANAGEMENT$252
- ETERNA$163
How this compares
$4,285 in reported general payments places this provider in the 45th percentile of 52 interventional pain medicine providers in Virginia.
See all interventional pain medicine providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 29 | $6,010 |
| Pregabalin | 112 | $4,106 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 158 | $3,999 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 164 | $2,696 |
| Gabapentin | 165 | $2,432 |
| Naloxone Hcl | 43 | $2,118 |
| Duloxetine Hcl | 78 | $1,244 |
| Diclofenac Sodium | 45 | $1,060 |
| Fentanyl | 13 | $1,058 |
| Celecoxib | 19 | $1,028 |
| Tizanidine Hcl | 87 | $969 |
| Tramadol Hcl ErTramadol Hcl | 11 | $686 |
| Tramadol Hcl | 107 | $596 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $376 |
| Methocarbamol | 43 | $374 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Newport News
- Che TorryNewport News$48K
- Raj SurejaNewport News$23K
- Ketan PatelHaymarket$133K
- Niteesh BhararaReston$25K
- Sassan HassassianManassas$24K
- Benjamin SeemanRichmond$21K
- Alok GopalWinchester$16K
- Jacob LeeWinchester$14K
- Yaoming GuRichmond$13K
- Rae DavisLansdowne$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.